---

Dean Ho

Dean is Professor and Co-Director of the Weintraub Center for Reconstructive Biotechnology at the UCLA School of Dentistry, and an internationally recognized leader in personalized medicine and nanomedicine. Recently, he successfully led a landmark clinical study to individualize immunosuppression, substantially improving patient outcomes. He has also pioneered the development of nanodiamond-based diagnostic platforms and drug delivery agents. “I chose to go into nanomedicine given the marked enhancements to both diagnostics and therapy that can be uniquely enabled using nanomaterials,” he explains. “Nanomedicine has the ability to overcome many of the challenges that confront the fields of pathology and laboratory medicine.”
What exciting things does Dean, a former president of the Society for Laboratory Automation and Screening, anticipate for pathology? His top picks include new technologies for tissue image analysis, digitally tailored combination therapies, and the use of nanomedicine to enhance laboratory medicine.

---

Part of the Power List 2016

The “rising stars” of pathology.

All too often, when considering the movers and shakers in any given field, those who are on their way up are overlooked.
This year, we shift the Power List spotlight to focus on the next generation of laboratory medicine – the “rising stars” of pathology.
You nominated. An esteemed panel of judges deliberated. And here it is...

Go to The Power List 2016